<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39180511</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1582-4934</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>16</Issue><PubDate><Year>2024</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of cellular and molecular medicine</Title><ISOAbbreviation>J Cell Mol Med</ISOAbbreviation></Journal><ArticleTitle>Impaired instructive and protective barrier functions of the endothelial cell glycocalyx pericellular matrix is impacted in COVID-19 disease.</ArticleTitle><Pagination><StartPage>e70033</StartPage><MedlinePgn>e70033</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70033</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/jcmm.70033</ELocationID><Abstract><AbstractText>The aim of this study was to review the roles of endothelial cells in normal tissue function and to show how COVID-19 disease impacts on endothelial cell properties that lead to much of its associated symptomatology. This places the endothelial cell as a prominent cell type to target therapeutically in the treatment of this disorder. Advances in glycosaminoglycan analytical techniques and functional glycomics have improved glycosaminoglycan mimetics development, providing agents that can more appropriately target various aspects of the behaviour of the endothelial cell in-situ and have also provided polymers with potential to prevent viral infection. Thus, promising approaches are being developed to combat COVID-19 disease and the plethora of symptoms this disease produces. Glycosaminoglycan mimetics that improve endothelial glycocalyx boundary functions have promising properties in the prevention of viral infection, improve endothelial cell function and have disease-modifying potential. Endothelial cell integrity, forming tight junctions in cerebral cell populations in the blood-brain barrier, prevents the exposure of the central nervous system to circulating toxins and harmful chemicals, which may contribute to the troublesome brain fogging phenomena reported in cognitive processing in long COVID disease.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Margaret M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Raymond Purves Bone and Joint Research Laboratory, Kolling Institute, Northern Sydney Local Health District, St. Leonards, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Arthropharm Australia Pharmaceuticals Pty Ltd, Bondi Junction, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melrose</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9237-0524</Identifier><AffiliationInfo><Affiliation>Raymond Purves Bone and Joint Research Laboratory, Kolling Institute, Northern Sydney Local Health District, St. Leonards, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School, Northern, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health, The University of Sydney, Royal North Shore Hospital, St. Leonards, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Melrose Personal Research Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cell Mol Med</MedlineTA><NlmUniqueID>101083777</NlmUniqueID><ISSNLinking>1582-1838</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006025">Glycosaminoglycans</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019276" MajorTopicYN="Y">Glycocalyx</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="Y">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="Y">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006025" MajorTopicYN="N">Glycosaminoglycans</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">blood flow regulation</Keyword><Keyword MajorTopicYN="N">endothelial cell</Keyword><Keyword MajorTopicYN="N">endothelium</Keyword><Keyword MajorTopicYN="N">glycocalyx</Keyword><Keyword MajorTopicYN="N">glypican</Keyword><Keyword MajorTopicYN="N">perlecan</Keyword><Keyword MajorTopicYN="N">shear flow</Keyword><Keyword MajorTopicYN="N">smooth muscle cell regulation</Keyword><Keyword MajorTopicYN="N">syndecan</Keyword></KeywordList><CoiStatement>J.M. has received consultancy fees from Arthropharm Pharmaceuticals Pty Ltd, Bondi, Sydney, Australia. M.M.S. is a clinical research director at Arthropharm Pharmaceuticals Pty Ltd. The authors have no conflicts to report. This company had no input into the interpretation of this study or the reason to publish.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>10</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39180511</ArticleId><ArticleId IdType="pmc">PMC11344469</ArticleId><ArticleId IdType="doi">10.1111/jcmm.70033</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kr&#xfc;ger&#x2010;Genge A, Blocki A, Franke RP, Jung F. Vascular endothelial cell biology: an update. Int J Mol Sci. 2019;20:4411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6769656</ArticleId><ArticleId IdType="pubmed">31500313</ArticleId></ArticleIdList></Reference><Reference><Citation>Pober J, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev. 1990;70:427&#x2010;451.</Citation><ArticleIdList><ArticleId IdType="pubmed">1690903</ArticleId></ArticleIdList></Reference><Reference><Citation>Pate M, Damarla V, Chi DS, Negi S, Krishnaswamy G. Endothelial cell biology: role in the inflammatory response. Adv Clin Chem. 2010;52:109&#x2010;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">21275341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond). 2005;108:205&#x2010;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">15540988</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper W, Catravas JD, Heistad DD, Sessa WC, Mensah GA. Vascular endothelium summary statement I: health promotion and chronic disease prevention. Vasc Pharmacol. 2007;46:315&#x2010;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">17197248</ArticleId></ArticleIdList></Reference><Reference><Citation>Polovina M, Potpara TS. Endothelial dysfunction in metabolic and vascular disorders. Postgrad Med. 2014;126:38&#x2010;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">24685967</ArticleId></ArticleIdList></Reference><Reference><Citation>Gimbrone MJ. Endothelial dysfunction and atherosclerosis. J Card Surg. 1989;4:180&#x2010;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">2519996</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran P, Rengarajan T, Thangavel J, et&#xa0;al. The vascular endothelium and human diseases. Int J Biol Sci. 2013;9:1057&#x2010;1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3831119</ArticleId><ArticleId IdType="pubmed">24250251</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson E, Cepinskas G, Fraser DD. Endothelial glycocalyx degradation in critical illness and injury. Front Med (Lausanne). 2022;9:898592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9304628</ArticleId><ArticleId IdType="pubmed">35872762</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomita H, Suzuki K, Komatsu M, Okada H. Editorial: vascular endothelial glycocalyx in cardiovascular disease. Front Cardiovasc Med. 2022;9:952022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9284031</ArticleId><ArticleId IdType="pubmed">35845081</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellenthal K, Brabenec L, Wagner NM. Regulation and dysregulation of endothelial permeability during systemic inflammation. Cells. 2022;11:1935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9221661</ArticleId><ArticleId IdType="pubmed">35741064</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Ciaula A, Liberale L, Portincasa P, et&#xa0;al. Neutrophil degranulation, endothelial and metabolic dysfunction in unvaccinated long COVID patients. Eur J Clin Investig. 2024;54:e14155. doi:10.1111/eci.14155</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.14155</ArticleId><ArticleId IdType="pubmed">38226472</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui K, Ma Z, Dimmeler S. SARS&#x2010;CoV&#x2010;2 induced vascular endothelial dysfunction: direct or indirect effects? Cardiovasc Res. 2024;120:34&#x2010;43. doi:10.1093/cvr/cvad191</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvad191</ArticleId><ArticleId IdType="pubmed">38159046</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi A, Singh RB, Rizvi AA, Dehgani&#x2010;Mobaraki P, Palladino N. COVID&#x2010;19 pathogenesis. Prog Mol Biol Transl Sci. 2024;202:67&#x2010;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">38237991</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki A, Tomita H, Okada H. Form follows function: the endothelial glycocalyx. Transl Res. 2022;247:158&#x2010;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">35421613</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry F. The molecular structure of the endothelial glycocalyx layer (EGL) and surface layers (ESL) modulation of transvascular exchange. Adv Exp Med Biol. 2018;1097:29&#x2010;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">30315538</ArticleId></ArticleIdList></Reference><Reference><Citation>Foote C, Soares RN, Ramirez&#x2010;Perez FI, et&#xa0;al. Endothelial glycocalyx. Compr Physiol. 2022;12:3781&#x2010;3811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214841</ArticleId><ArticleId IdType="pubmed">35997082</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius D, Richter RP, Anand T, Cardenas JC, Richter JR. Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function. Matrix Biol Plus. 2022;16:100121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494232</ArticleId><ArticleId IdType="pubmed">36160687</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Shen Y, Shang M, Liu X, Munn LL. Endothelial mechanobiology in atherosclerosis. Cardiovasc Res. 2023;119:1656&#x2010;1675. doi:10.1093/cvr/cvad076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvad076</ArticleId><ArticleId IdType="pmc">PMC10325702</ArticleId><ArticleId IdType="pubmed">37163659</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo T, Banuth AMM, Nader HB, Dreyfuss JL. Altered shear stress on endothelial cells leads to remodeling of extracellular matrix and induction of angiogenesis. PLoS One. 2020;15:e0241040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7676693</ArticleId><ArticleId IdType="pubmed">33211705</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartosch A, Mathews R, Mahmoud MM, Cancel LM, Haq ZS, Tarbell JM. Heparan sulfate proteoglycan glypican&#x2010;1 and PECAM&#x2010;1 cooperate in shear&#x2010;induced endothelial nitric oxide production. Sci Rep. 2021;11:11386.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8166914</ArticleId><ArticleId IdType="pubmed">34059731</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Y, Liu J. Role of glypican&#x2010;1 in endothelial NOS activation under various steady shear stress magnitudes. Exp Cell Res. 2016;348:184&#x2010;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">27688027</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel G, Meyer&#x2010;Rath G, Ermilov E, et&#xa0;al. Flow sensing in the cardiovascular system. Colloids Surf A Physiochem Eng Asp. 2015;480:318&#x2010;327.</Citation></Reference><Reference><Citation>Siegel G, Malmsten M, Ermilov E. Anionic biopolyelectrolytes of the syndecan/perlecan superfamily: physicochemical properties and medical significance. Adv Colloid Interf Sci. 2014;205:275&#x2010;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">24534475</ArticleId></ArticleIdList></Reference><Reference><Citation>Masola V, Greco N, Gambaro G, Franchi M, Onisto M. Heparanase as active player in endothelial glycocalyx remodeling. Matrix Biol Plus. 2021;13:100097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8749438</ArticleId><ArticleId IdType="pubmed">35036899</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell D, Jacob M, Paul O, et&#xa0;al. The glycocalyx of the human umbilical vein endothelial cell: an impressive structure ex&#xa0;vivo but not in culture. Circ Res. 2009;104:1313&#x2010;1317.</Citation><ArticleIdList><ArticleId IdType="pubmed">19423849</ArticleId></ArticleIdList></Reference><Reference><Citation>Klitzman B, Duling BR. Microvascular hematocrit and red cell flow in resting and contracting striated muscle. Am J Phys. 1979;237:H481&#x2010;H490.</Citation><ArticleIdList><ArticleId IdType="pubmed">495734</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwdorp M, Meuwese MC, Mooij HL, et&#xa0;al. Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. J Appl Physiol (1985). 2008;104:845&#x2010;852.</Citation><ArticleIdList><ArticleId IdType="pubmed">18162484</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieuwdorp M, van Haeften TW, Gouverneur MCLG, et&#xa0;al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in&#xa0;vivo. Diabetes. 2006;55:480&#x2010;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">16443784</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt E, Yang Y, Janssen WJ, et&#xa0;al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med. 2012;18:1217&#x2010;1223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3723751</ArticleId><ArticleId IdType="pubmed">22820644</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res. 1996;79:581&#x2010;589.</Citation><ArticleIdList><ArticleId IdType="pubmed">8781491</ArticleId></ArticleIdList></Reference><Reference><Citation>Alphonsus C, Rodseth RN. The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia. 2014;69:777&#x2010;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">24773303</ArticleId></ArticleIdList></Reference><Reference><Citation>Barale C, Melchionda E, Morotti A, Russo I. Prothrombotic phenotype in COVID&#x2010;19: focus on platelets. Int J Mol Sci. 2021;22:13638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8705811</ArticleId><ArticleId IdType="pubmed">34948438</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry F, Adamson RH. Endothelial glycocalyx: permeability barrier and mechanosensor. Ann Biomed Eng. 2011;40:828&#x2010;839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5042904</ArticleId><ArticleId IdType="pubmed">22009311</ArticleId></ArticleIdList></Reference><Reference><Citation>Haymet A, Bartnikowski N, Wood ES, et&#xa0;al. Studying the endothelial glycocalyx in&#xa0;vitro: what is missing? Front Cardiovasc Med. 2021;8:647086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8079726</ArticleId><ArticleId IdType="pubmed">33937360</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilak F, Hayes AJ, Melrose J. Perlecan in pericellular mechanosensory cell&#x2010;matrix communication, extracellular matrix stabilisation and mechanoregulation of load&#x2010;bearing connective tissues. Int J Mol Sci. 2021;22:2716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7962540</ArticleId><ArticleId IdType="pubmed">33800241</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes A, Lord MS, Smith SM, et&#xa0;al. Colocalization in&#xa0;vivo and association in&#xa0;vitro of perlecan and elastin. Histochem Cell Biol. 2011;136:437&#x2010;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">21874555</ArticleId></ArticleIdList></Reference><Reference><Citation>Krull C, Rife J, Klamer B, Purmessur D, Walter BA. Pericellular heparan sulfate proteoglycans: role in regulating the biosynthetic response of nucleus pulposus cells to osmotic loading. JOR Spine. 2022;5:e1209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238280</ArticleId><ArticleId IdType="pubmed">35783912</ArticleId></ArticleIdList></Reference><Reference><Citation>Melrose J. Hippo cell signaling and HS&#x2010;proteoglycans regulate tissue form and function, age&#x2010;dependent maturation, extracellular matrix remodelling and repair. Am J Physiol Cell Physiol. 2024;326:C810&#x2010;C828. doi:10.1152/ajpcell.00683.2023</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00683.2023</ArticleId><ArticleId IdType="pubmed">38223931</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Kuraishy H, Al&#x2010;Gareeb AI, Saad HM, Batiha GE. Hippo&#x2010;YAP signaling and SARS&#x2010;CoV&#x2010;2 infection: a new mechanistic pathway. Cell Stress Chaperones. 2023;28:121&#x2010;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9907175</ArticleId><ArticleId IdType="pubmed">36752973</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia GJ, Jeyachandran AV, Wang Y, et&#xa0;al. Hippo signaling pathway activation during SARS&#x2010;CoV&#x2010;2 infection contributes to host antiviral response. PLoS Biol. 2022;20:e3001851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9642871</ArticleId><ArticleId IdType="pubmed">36346780</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011;91:221&#x2010;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3051404</ArticleId><ArticleId IdType="pubmed">21248167</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida H, Okada Y. Role of HYBID (hyaluronan binding protein involved in hyaluronan depolymerization), alias KIAA1199/CEMIP, in hyaluronan degradation in normal and photoaged skin. Int J Mol Sci. 2019;20:5804. doi:10.3390/ijms20225804</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20225804</ArticleId><ArticleId IdType="pmc">PMC6888145</ArticleId><ArticleId IdType="pubmed">31752258</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino Y, Ishisaka M, Tsuruma K, et&#xa0;al. Distribution and function of hyaluronan binding protein involved in hyaluronan depolymerization (HYBID, KIAA1199) in the mouse central nervous system. Neuroscience. 2017;347:1&#x2010;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">28189611</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshino Y, Shimazawa M, Nakamura S, et&#xa0;al. Targeted deletion of HYBID (hyaluronan binding protein involved in hyaluronan depolymerization/KIAA1199/CEMIP) decreases dendritic spine density in the dentate gyrus through hyaluronan accumulation. Biochem Biophys Res Commun. 2018;503:1934&#x2010;1940.</Citation><ArticleIdList><ArticleId IdType="pubmed">30060951</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuller ES, Shu C, Smith MM, Little CB, Melrose J. Hyaluronan oligosaccharides stimulate matrix metalloproteinase and anabolic gene expression in&#xa0;vitro by intervertebral disc cells and annular repair in&#xa0;vivo. J Tissue Eng Regen Med. 2018;12:e216&#x2010;e226. doi:10.1002/term.2319</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/term.2319</ArticleId><ArticleId IdType="pubmed">27689852</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanabayashi M, Takahashi N, Sobue Y, Hirabara S, Ishiguro N, Kojima T. Hyaluronan oligosaccharides induce MMP&#x2010;1 and &#x2010;3 via transcriptional activation of NF&#x2010;&#x3ba;B and p 38 MAPK in rheumatoid synovial fibroblasts. PLoS One. 2016;11:e016187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5001728</ArticleId><ArticleId IdType="pubmed">27564851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno S, Im HJ, Knudson CB, Knudson W. Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFkappaB and p38 MAP kinase in articular chondrocytes. J Biol Chem. 2006;281:17952&#x2010;17960.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139229</ArticleId><ArticleId IdType="pubmed">16648633</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishida&#x2010;Fukuda H, Araki R, Shudou M, et&#xa0;al. Ectodomain shedding of lymphatic vessel endothelial Hyaluronan receptor 1 (LYVE&#x2010;1) is induced by vascular endothelial growth factor a (VEGF&#x2010;A). J Biol Chem. 2016;291:10490&#x2010;10500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4865900</ArticleId><ArticleId IdType="pubmed">26966180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bono P, Cordero E, Johnson K, et&#xa0;al. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin. Exp Cell Res. 2005;308:177&#x2010;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">15913605</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Liu YJ, Wang H, Xu Y, Stamenkovic I, Yu Q. Inhibition of the hyaluronan&#x2010;CD44 interaction by merlin contributes to the tumor&#x2010;suppressor activity of merlin. Oncogene. 2007;26:836&#x2010;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">16953231</ArticleId></ArticleIdList></Reference><Reference><Citation>Falkowski M, Schledzewski K, Hansen B, Goerdt S. Expression of stabilin&#x2010;2, a novel fasciclin&#x2010;like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces. Histochem Cell Biol. 2003;120:361&#x2010;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">14598175</ArticleId></ArticleIdList></Reference><Reference><Citation>Politz O, Gratchev A, McCourt PA, et&#xa0;al. Stabilin&#x2010;1 and &#x2010;2 constitute a novel family of fasciclin&#x2010;like hyaluronan receptor homologues. Biochem J. 2002;362:155&#x2010;164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1222372</ArticleId><ArticleId IdType="pubmed">11829752</ArticleId></ArticleIdList></Reference><Reference><Citation>Palani S, Maksimow M, Miiluniemi M, Auvinen K, Jalkanen S, Salmi M. Stabilin&#x2010;1/CLEVER&#x2010;1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages. Eur J Immunol. 2011;41:2020&#x2010;2063.</Citation><ArticleIdList><ArticleId IdType="pubmed">21480214</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikoski M, Irjala H, Maksimow M, et&#xa0;al. Clever&#x2010;1/Stabilin&#x2010;1 regulates lymphocyte migration within lymphatics and inflamed blood vessels at sites of inflammation. Eur J Immunol. 2009;39:3477&#x2010;3487.</Citation><ArticleIdList><ArticleId IdType="pubmed">19830743</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigel P. Discovery of the liver Hyaluronan receptor for endocytosis (HARE) and its progressive emergence as the multi&#x2010;ligand scavenger receptor Stabilin&#x2010;2. Biomol Ther. 2019;9(9):454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6769870</ArticleId><ArticleId IdType="pubmed">31500161</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris E, Kyosseva SV, Weigel JA, Weigel PH. Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315&#x2010;kDa hyaluronic acid receptor for endocytosis (HARE). J Biol Chem. 2007;282:2785&#x2010;2797.</Citation><ArticleIdList><ArticleId IdType="pubmed">17145755</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris E, Cabral F. Ligand Binding and Signaling of HARE/Stabilin&#x2010;2. Biomol Ther. 2019;9:273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6681266</ArticleId><ArticleId IdType="pubmed">31336723</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris E, Weigel PH. The ligand&#x2010;binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low&#x2010;density lipoprotein, dermatan sulfate, and CS&#x2010;E. Glycobiology. 2008;18:638&#x2010;648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2561176</ArticleId><ArticleId IdType="pubmed">18499864</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey M, Weigel PH. Hyaluronic acid receptor for endocytosis (HARE)&#x2010;mediated endocytosis of hyaluronan, heparin, dermatan sulfate, and acetylated low density lipoprotein (AcLDL), but not chondroitin sulfate types A, C, D, or E, activates NF&#x2010;&#x3ba;B&#x2010;regulated gene expression. J Biol Chem. 2014;289:1756&#x2010;1767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3894352</ArticleId><ArticleId IdType="pubmed">24247245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeidler J, Hogan KA, Agorrody G, et&#xa0;al. The CD38 glycohydrolase and the NAD sink: implications for pathological conditions. Am J Physiol Cell Physiol. 2022;322:C521&#x2010;C545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8917930</ArticleId><ArticleId IdType="pubmed">35138178</ArticleId></ArticleIdList></Reference><Reference><Citation>Inzhutova A, Salmina AB, Petrova MM, Larionov AA. Role of CD38 in cell&#x2010;cell interactions under conditions of endothelial dysfunction. Bull Exp Biol Med. 2008;145:703&#x2010;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">19110555</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishina H, Inageda K, Takahashi K, Hoshino S, Ikeda K, Katada T. Cell surface antigen CD38 identified as ecto&#x2010;enzyme of NAD glycohydrolase has hyaluronate&#x2010;binding activity. Biochem Biophys Res Commun. 1994;203:1318&#x2010;1323.</Citation><ArticleIdList><ArticleId IdType="pubmed">8093047</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrero E, Malavasi F. Human CD38, a leukocyte receptor and ectoenzyme, is a member of a novel eukaryotic gene family of nicotinamide adenine dinucleotide &#xb1; converting enzymes: extensive structural homology with the genes for murine bone marrow stromal cell antigen 1 and aplysian ADP&#x2010;ribosyl cyclase. J Immunol. 1997;159:3858&#x2010;3865.</Citation><ArticleIdList><ArticleId IdType="pubmed">9378973</ArticleId></ArticleIdList></Reference><Reference><Citation>Musso T, Deaglio S, Franco L, et&#xa0;al. CD38 expression and functional activities are up&#x2010;regulated by IFN&#x2010;gamma on human monocytes and monocytic cell lines. J Leukoc Biol. 2001;69:605&#x2010;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">11310847</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins S, Blank RS, Deatherage LS, Dull RO. Special article: the endothelial glycocalyx: emerging concepts in pulmonary edema and acute lung injury. Anesth Analg. 2013;117:664&#x2010;674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3790575</ArticleId><ArticleId IdType="pubmed">23835455</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada H, Yoshida S, Hara A, Ogura S, Tomita H. Vascular endothelial injury exacerbates coronavirus disease 2019: the role of endothelial glycocalyx protection. Microcirculation. 2021;28:e12654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435519</ArticleId><ArticleId IdType="pubmed">32791568</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee C, Penno MB, Cowman M, et&#xa0;al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest. 1996;98:2403&#x2010;2413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC507693</ArticleId><ArticleId IdType="pubmed">8941660</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson P, Arif AA, Lee&#x2010;Sayer SSM, Dong Y. Hyaluronan and its interactions with immune cells in the healthy and inflamed lung. Front Immunol. 2018;9:2787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6281886</ArticleId><ArticleId IdType="pubmed">30555472</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mesy Bentley K. An 11&#x2010;&#x3bc;m&#x2010;thick glycocalyx? It's all in the technique! Arterioscler Thromb Vasc Biol. 2011;31:1712&#x2010;1713.</Citation><ArticleIdList><ArticleId IdType="pubmed">21775768</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H, Song Y, Chen Y, et&#xa0;al. Molecular architecture of the SARS&#x2010;CoV&#x2010;2 virus. Cell. 2020;183:730&#x2010;738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474903</ArticleId><ArticleId IdType="pubmed">32979942</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS&#x2010;CoV&#x2010;2 by full&#x2010;length human ACE2. Science. 2020;367:1444&#x2010;1448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshima K, King SI, McMurtry SA, Schmidt EP. Endothelial heparan sulfate proteoglycans in sepsis: the role of the glycocalyx. Semin Thromb Hemost. 2021;47:274&#x2010;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">33794552</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter J, Sanderson RD. The glycocalyx: pathobiology and repair. Matrix Biol Plus. 2023;17:100128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9923180</ArticleId><ArticleId IdType="pubmed">36793504</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarbell J, Cancel LM. The glycocalyx and its significance in human medicine. J Intern Med. 2016;280:97&#x2010;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">26749537</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinbaum S, Cancel LM, Fu BM, Tarbell JM. The glycocalyx and its role in vascular physiology and vascular related diseases. Cardiovasc Eng Technol. 2021;12:37&#x2010;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7505222</ArticleId><ArticleId IdType="pubmed">32959164</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez Toledo A, Sorrentino JT, Sandoval DR, Malmstr&#xf6;m J, Lewis NE, Esko JD. A systems view of the heparan sulfate interactome. J Histochem Cytochem. 2021;69:105&#x2010;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841697</ArticleId><ArticleId IdType="pubmed">33494649</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrugia B, Melrose J. The glycosaminoglycan side chains and modular core proteins of heparan sulphate proteoglycans and the varied ways they provide tissue protection by regulating physiological processes and cellular behaviour. Int J Mol Sci. 2023;24:14101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10531531</ArticleId><ArticleId IdType="pubmed">37762403</ArticleId></ArticleIdList></Reference><Reference><Citation>Carey D. Syndecans: multifunctional cell&#x2010;surface co&#x2010;receptors. Biochem J. 1997;327:1&#x2010;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1218755</ArticleId><ArticleId IdType="pubmed">9355727</ArticleId></ArticleIdList></Reference><Reference><Citation>Afratis N, Nikitovic D, Multhaupt HA, Theocharis AD, Couchman JR, Karamanos NK. Syndecans&#x2014;key regulators of cell signaling and biological functions. FEBS J. 2017;284:27&#x2010;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">27790852</ArticleId></ArticleIdList></Reference><Reference><Citation>Askari H, Sadeghinejad M, Fancher IS. Mechanotransduction and the endothelial glycocalyx: interactions with membrane and cytoskeletal proteins to transduce force. Curr Top Membr. 2023;91:43&#x2010;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">37080680</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, Le Y, Li S, Bian Y. Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS). Respir Res. 2024;25:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10788036</ArticleId><ArticleId IdType="pubmed">38218783</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmani M, Chegini R, Ghanbari E, et&#xa0;al. Severe acute respiratory syndrome coronavirus 2 infection: role of interleukin&#x2010;6 and the inflammatory cascade. World J Virol. 2022;11:113&#x2010;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9150027</ArticleId><ArticleId IdType="pubmed">35665236</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharra R, Kumar Sharma A, Datta S. Emerging aspects of cytokine storm in COVID&#x2010;19: the role of proinflammatory cytokines and therapeutic prospects. Cytokine. 2023;169:156287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10291296</ArticleId><ArticleId IdType="pubmed">37402337</ArticleId></ArticleIdList></Reference><Reference><Citation>Shekhawat J, Gauba K, Gupta S, et&#xa0;al. Interleukin&#x2010;6 perpetrator of the COVID&#x2010;19 cytokine storm. Indian J Clin Biochem. 2021;36:440&#x2010;450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8216093</ArticleId><ArticleId IdType="pubmed">34177139</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R, Kanneganti TD. The &#x2018;cytokine storm&#x2019;: molecular mechanisms and therapeutic prospects. Trends Immunol. 2021;42:681&#x2010;705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9310545</ArticleId><ArticleId IdType="pubmed">34217595</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, et&#xa0;al. T.COVID&#x2010;19 infection: an overview on cytokine storm and related interventions. Virol J. 2022;19:92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu K, Borogovac A, Cerny J. COVID&#x2010;19 related immune hemolysis and thrombocytopenia. J Med Virol. 2021;93:1164&#x2010;1170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436763</ArticleId><ArticleId IdType="pubmed">32776538</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhter N, Ahmad S, Alzahrani FA, et&#xa0;al. Impact of COVID&#x2010;19 on the cerebrovascular system and the prevention of RBC lysis. Eur Rev Med Pharmacol Sci. 2020;24:10267&#x2010;10278.</Citation><ArticleIdList><ArticleId IdType="pubmed">33090438</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J, Booth GS. GS.COVID&#x2010;19 and immune&#x2010;mediated RBC destruction. Am J Clin Pathol. 2022;157:844&#x2010;851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755306</ArticleId><ArticleId IdType="pubmed">34919640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin E, Ara JE, Markantonis J, Luu H, Chen M. Hematologic complications in patients hospitalized with COVID&#x2010;19 infection. Hematol Rep. 2022;14:228&#x2010;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9326587</ArticleId><ArticleId IdType="pubmed">35893155</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasa P, Juneja D, Jain R, Nasa R. COVID&#x2010;19 and hemolysis, elevated liver enzymes and thrombocytopenia syndrome in pregnant women&#x2014;association or causation? World J Virol. 2022;11:310&#x2010;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9523323</ArticleId><ArticleId IdType="pubmed">36188744</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M, Umeton RP, Keyhanian K, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 and acute cerebrovascular events: an overview. J Clin Med. 2021;10:3349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8348889</ArticleId><ArticleId IdType="pubmed">34362133</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdary P. COVID&#x2010;19 coagulopathy&#x2014;what should we treat? Exp Physiol. 2022;107:749&#x2010;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9328279</ArticleId><ArticleId IdType="pubmed">35733235</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrill J, Erkan D, Winakur J, James JA. Emerging evidence of a COVID&#x2010;19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020;16:581&#x2010;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391481</ArticleId><ArticleId IdType="pubmed">32733003</ArticleId></ArticleIdList></Reference><Reference><Citation>Pl&#xe1;&#x161;ek J, Gumulec J, M&#xe1;ca J, et&#xa0;al. COVID&#x2010;19 associated coagulopathy: mechanisms and host&#x2010;directed treatment. Am J Med Sci. 2022;363:465&#x2010;475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576106</ArticleId><ArticleId IdType="pubmed">34752741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hingorani K, Bhadola S, Cervantes&#x2010;Arslanian AM. COVID&#x2010;19 and the brain. Trends Cardiovasc Med. 2022;32:323&#x2010;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9022395</ArticleId><ArticleId IdType="pubmed">35461991</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdouleh E, Alhamlan F, Al&#x2010;Qahtani AA, et&#xa0;al. Changes in the fibrinolytic system of patients infected with severe acute respiratory syndrome coronavirus 2. J Clin Med. 2023;12:5223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10455675</ArticleId><ArticleId IdType="pubmed">37629265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes&#x2010;Filho SPM, de Souza Pinheiro R, Martins FS, et&#xa0;al. Kinetics of IL&#x2010;6, C&#x2010;reactive protein and fibrinogen levels in COVID&#x2010;19 outpatients who evolved to hypoxemia. Clin Pathol. 2024;17:2632010X231222795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10768631</ArticleId><ArticleId IdType="pubmed">38188270</ArticleId></ArticleIdList></Reference><Reference><Citation>Budzynski A. Fibrinogen and fibrin: biochemistry and pathophysiology. Crit Rev Oncol Hematol. 1986;6:97&#x2010;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">2878736</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosmi B, Legnani C, Libra A, Palareti G. D&#x2010;dimers in diagnosis and prevention of venous thrombosis: recent advances and their practical implications. Pol Arch Intern Med. 2023;133:16604.</Citation><ArticleIdList><ArticleId IdType="pubmed">37965939</ArticleId></ArticleIdList></Reference><Reference><Citation>Wool G, Miller JL. The impact of COVID&#x2010;19 disease on platelets and coagulation. Pathobiology. 2021;88:15&#x2010;27. doi:10.1159/000512007</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512007</ArticleId><ArticleId IdType="pmc">PMC7649697</ArticleId><ArticleId IdType="pubmed">33049751</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID&#x2010;19. J Thromb Haemost. 2020;18:2103&#x2010;2109. doi:10.1111/jth.14975</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14975</ArticleId><ArticleId IdType="pmc">PMC7323352</ArticleId><ArticleId IdType="pubmed">32558075</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobler C, Maphumulo SC, Grobbelaar LM, et&#xa0;al. Covid&#x2010;19: the rollercoaster of fibrin(Ogen), D&#x2010;dimer, Von Willebrand factor, P&#x2010;selectin and their interactions with endothelial cells, platelets and erythrocytes. Int J Mol Sci. 2020;21:5168. doi:10.3390/ijms21145168</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145168</ArticleId><ArticleId IdType="pmc">PMC7403995</ArticleId><ArticleId IdType="pubmed">32708334</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xf6;gtle T, Sharma S, Mori J, et&#xa0;al. Heparan sulfates are critical regulators of the inhibitory megakaryocyte&#x2010;platelet receptor G6b&#x2010;B. elife. 2019;8:e46840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742478</ArticleId><ArticleId IdType="pubmed">31436532</ArticleId></ArticleIdList></Reference><Reference><Citation>Koupenova M, Corkrey HA, Vitseva O, et&#xa0;al. SARS&#x2010;CoV&#x2010;2 initiates programmed cell death in platelets. Circ Res. 2021;129:631&#x2010;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409903</ArticleId><ArticleId IdType="pubmed">34293929</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord M, Tang F, Rnjak&#x2010;Kovacina J, Smith JGW, Melrose J, Whitelock JM. The multifaceted roles of perlecan in fibrosis. Matrix Biol. 2018;68&#x2013;69:150&#x2010;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">29475023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord M, Chuang CY, Melrose J, Davies MJ, Iozzo RV, Whitelock JM. The role of vascular&#x2010;derived perlecan in modulating cell adhesion, proliferation and growth factor signaling. Matrix Biol. 2014;35:112&#x2010;122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5030467</ArticleId><ArticleId IdType="pubmed">24509440</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitelock J, Melrose J, Iozzo RV. Diverse cell signaling events modulated by perlecan. Biochemistry. 2008;47:11174&#x2010;11183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2605657</ArticleId><ArticleId IdType="pubmed">18826258</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccatonda A, Campello E, Simion C, Simioni P. Long&#x2010;term hypercoagulability, endotheliopathy and inflammation following acute SARS&#x2010;CoV&#x2010;2 infection. Expert Rev Hematol. 2023;16:1035&#x2010;1048.</Citation><ArticleIdList><ArticleId IdType="pubmed">38018136</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto M, Perucci LO, Tavares LP, Teixeira MM, Sousa LP. Fibrinolysis in COVID&#x2010;19: impact on clot lysis and modulation of inflammation. Curr Drug Targets. 2022;23:1578&#x2010;1592.</Citation><ArticleIdList><ArticleId IdType="pubmed">36221881</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastry S, Cuomo F, Muthusamy J. COVID&#x2010;19 and thrombosis: the role of hemodynamics. Thromb Res. 2022;212:51&#x2010;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8864963</ArticleId><ArticleId IdType="pubmed">35219932</ArticleId></ArticleIdList></Reference><Reference><Citation>Armonis C, Komnianou K, Grigoropoulou P, et&#xa0;al. Glycemic and lipid profile of patients with COVID&#x2010;19: impact on morbidity and mortality. Clin Nutr ESPEN. 2023;58:362&#x2010;367.</Citation><ArticleIdList><ArticleId IdType="pubmed">38057028</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley K. The role of selectins in inflammation and disease. Trends Mol Med. 2003;9:263&#x2010;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">12829015</ArticleId></ArticleIdList></Reference><Reference><Citation>Purdy M, Obi A, Myers D, Wakefield T. P&#x2010; and E&#x2010; selectin in venous thrombosis and non&#x2010;venous pathologies. J Thromb Haemost. 2022;20:1056&#x2010;1066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9314977</ArticleId><ArticleId IdType="pubmed">35243742</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhargavan B, Kanmogne GD. SARS&#x2010;CoV&#x2010;2 spike proteins and cell&#x2013;cell communication induce P&#x2010;selectin and markers of endothelial injury, NETosis, and inflammation in human lung microvascular endothelial cells and neutrophils: implications for the pathogenesis of COVID&#x2010;19 coagulopathy. Int J Mol Sci. 2023;24:12585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10454213</ArticleId><ArticleId IdType="pubmed">37628764</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina&#x2010;Leyte D, Zepeda&#x2010;Garc&#xed;a O, Dom&#xed;nguez&#x2010;P&#xe9;rez M, Gonz&#xe1;lez&#x2010;Garrido A, Villarreal&#x2010;Molina T, Jacobo&#x2010;Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising Therapeutical approaches. Int J Mol Sci. 2021;22:3850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8068178</ArticleId><ArticleId IdType="pubmed">33917744</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J, Ho M. Role of glypican&#x2010;1 in regulating multiple cellular signaling pathways. Am J Physiol Cell Physiol. 2021;321:C846&#x2010;C858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8616591</ArticleId><ArticleId IdType="pubmed">34550795</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglakelidze N, Manto KM, Craig TJ. A review: does complement or the contact system have a role in protection or pathogenesis of COVID&#x2010;19? Pulm Ther. 2020;6:169&#x2010;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7218701</ArticleId><ArticleId IdType="pubmed">32405877</ArticleId></ArticleIdList></Reference><Reference><Citation>de Maistre E, Savard P, Guinot PG. COVID&#x2010;19 and the concept of Thrombo&#x2010;inflammation: review of the relationship between immune response, endothelium and coagulation. J Clin Med. 2023;12:7245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10706970</ArticleId><ArticleId IdType="pubmed">38068297</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia&#x2010;Hasler C, Br&#xfc;ningk SC, Hoch T, et&#xa0;al. Persistent complement dysregulation with signs of thromboinflammation in active long Covid. Science. 2024;383:eadg7942.</Citation><ArticleIdList><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruf W. Immune damage in Long Covid. Science. 2024;383:262&#x2010;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">38236985</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson J, Frost S, Keyashian K, Modiano N. Pentosan polysulfate&#x2010;associated dysplasia in patients with inflammatory bowel disease: a case series. Am J Gastroenterol. 2023;118:905&#x2010;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">36689730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh P, Wu J, Shimmon S, Zannettino AC, Gronthos S, Itescu S. Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow&#x2010;derived mesenchymal precursor cells. Arthritis Res Ther. 2010;12:R28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2875662</ArticleId><ArticleId IdType="pubmed">20167057</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M, Melrose J. Pentosan polysulfate affords pleotropic protection to multiple cells and tissues. Pharmaceuticals (Basel). 2023;16:437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10132487</ArticleId><ArticleId IdType="pubmed">36986536</ArticleId></ArticleIdList></Reference><Reference><Citation>Veszelka S, P&#xe1;szt&#xf3;i M, Farkas AE, et&#xa0;al. Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide&#x2010;induced damages. Neurochem Int. 2007;50:219&#x2010;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">16997427</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M, Hayes AJ, Melrose J. Pentosan polysulfate, a semisynthetic heparinoid disease&#x2010;modifying osteoarthritic drug with roles in intervertebral disc repair biology emulating the stem cell instructive and tissue reparative properties of heparan sulfate. Stem Cells Dev. 2022;31:406&#x2010;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">35102748</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;ckl L. The emerging role of the mammalian glycocalyx in functional membrane organization and immune system regulation. Front Cell Dev Biol. 2020;8:253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7174505</ArticleId><ArticleId IdType="pubmed">32351961</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRivi&#xe8;re W, Schmidt EP. The pulmonary endothelial glycocalyx in ARDS: a critical role for heparan sulfate. Curr Top Membr. 2018;82:33&#x2010;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">30360782</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, Egbrink MG. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007;454:345&#x2010;359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1915585</ArticleId><ArticleId IdType="pubmed">17256154</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker B, Chappell D, Bruegger D, Annecke T, Jacob M. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res. 2010;87:300&#x2010;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">20462866</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell S, Godula K. Synthetic glycoscapes: addressing the structural and functional complexity of the glycocalyx. Interface Focus. 2019;9:20180080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6388016</ArticleId><ArticleId IdType="pubmed">30842878</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;tt U, Solomon C, Fries D, Bentzer P. The endothelial glycocalyx and its disruption, protection and regeneration: a narrative review. Scand J Trauma Resusc Emerg Med. 2016;24:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828893</ArticleId><ArticleId IdType="pubmed">27068016</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Xu X, Xie S, et&#xa0;al. Improving impact of heparan sulfate on the endothelial glycocalyx abnormalities in atherosclerosis as revealed by glycan&#x2013;protein interactome. Carbohydr Polym. 2024;30:121834.</Citation><ArticleIdList><ArticleId IdType="pubmed">38368111</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazuma S, Tokinaga Y, Kimizuka M, Azumaguchi R, Hamada K, Yamakage M. Sevoflurane promotes regeneration of the endothelial glycocalyx by upregulating sialyltransferase. J Surg Res. 2019;241:40&#x2010;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">31004871</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Xie Y, Wong M, Mariana Barboza M, Lebrilla CB. Comprehensive structural glycomic characterization of the glycocalyxes of cells and tissues. Nat Protoc. 2020;15:2668&#x2010;2704.</Citation><ArticleIdList><ArticleId IdType="pubmed">32681150</ArticleId></ArticleIdList></Reference><Reference><Citation>Dane M, van den Berg BM, Lee DH, et&#xa0;al. A microscopic view on the renal endothelial glycocalyx. Am J Physiol Renal Physiol. 2015;308:F956&#x2010;F966.</Citation><ArticleIdList><ArticleId IdType="pubmed">25673809</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>